H100 Group (H100) H2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
H2 25/26 earnings summary
24 Feb, 2026Executive summary
2025 marked a transformative year, with a strategic pivot to a dual focus on health tech and Bitcoin treasury operations, including a reverse takeover and public listing in April.
The group accumulated 1,046 Bitcoin by year-end, becoming the largest listed Bitcoin treasury in the Nordics and among the top 50 globally.
Significant capital was raised (approx. SEK 1,189 MSEK) to support the Bitcoin strategy, and the company expanded its market presence to the US and Germany.
The fourth quarter was a period of consolidation, infrastructure building, and adaptation to weaker capital markets.
Financial highlights
Q4 net sales: 3 MSEK (up from 2.2 MSEK YoY); full-year net sales: 11.8 MSEK (down from 14.1 MSEK YoY).
Q4 operating loss (EBIT): -296.4 MSEK (vs. -0.4 MSEK YoY), with 291.7 MSEK from non-cash depreciation/impairment.
Full-year operating loss: -340.5 MSEK (vs. -0.3 MSEK YoY), with 324.2 MSEK from non-cash items.
Q4 loss after tax: -300.1 MSEK (vs. -0.5 MSEK YoY); full-year loss after tax: -354.8 MSEK (vs. -0.8 MSEK YoY).
Q4 EPS: -0.91 SEK (vs. -0.01 SEK YoY); full-year EPS: -1.76 SEK (vs. -0.02 SEK YoY).
Equity ratio at year-end: 91% (up from 43% YoY).
Outlook and guidance
No formal forecasts provided; focus remains on disciplined Bitcoin accumulation and health tech growth.
Strategic expansion into Switzerland via acquisition of Future Holdings AG in early 2026 to enhance institutional credibility and access to capital.
Latest events from H100 Group
- Scalable health tech platform leverages influencer networks for rapid, recurring global growth.H100
Status Update23 Nov 2025 - Accelerating Bitcoin Treasury and global health initiatives to empower sovereign individuals.H100
Status Update21 Nov 2025 - Strong sales growth and Bitcoin accumulation, but significant non-cash losses and volatility.H100
H1 25/2619 Nov 2025 - Revenue up 166%, net loss reduced, and strategic shift to digital health acquisition underway.H100
H1 24/2513 Jun 2025 - Annual loss deepened on portfolio write-downs; net asset value per share fell 22%.H100
H2 23/2413 Jun 2025 - Acquisition-driven transformation and capital infusion position H100 for digital health growth.H100
H2 24/2511 Jun 2025